TipRanks on MSN
Kissei Pharmaceutical’s Fostamatinib Study: A Potential Game-Changer for Chronic Thrombocytopenic Purpura
Kissei Pharmaceutical Co (($KSPHF)) announced an update on their ongoing clinical study. Study Overview: Kissei Pharmaceutical Co. is conducting a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback